Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FYTF-919 in Acute Intracerebral Haemorrhage
NCT05066620Phase 3Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Oct 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Zhongfengxingnao formula in intracerebral hemorrhage (ICH), sponsored by Guangzhou University of Chinese Medicine. Status: unknown.
02
Drugs
Zhongfengxingnao formula
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05066620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066620.